Sincalide (Sincalide) Patent Expiration, LOE Window & CMS Spending

Sincalide (Sincalide) by Maia: FDA Orange Book LOE 2038-04-20, 2 AB generics, $363K 2024 CMS Part D & Medicaid spend, and $1,241 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorMaia
FDA Application & PathwayN210850 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2038-04-20
Orange Book Patents (*PED Extensions)3 patents (0 *PED)
Active AB-Rated Generic Competitors2
2024 CMS Total Public Spend$363K
2024 Medicare Part D Spend$0
2024 Medicaid Spend$363K
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,241 intro WAC)